Infinity Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

12.10.23	INFI DEADLINE ALERT: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 16 Deadline in Securities Class Action - INFI (PR Newswire)
05.10.23	INFI IMPORTANT DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 16 Deadline in Securities Class Action - INFI (PR Newswire)
27.09.23	ROSEN, A LONGSTANDING LAW FIRM, Encourages Infinity Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - INFI (PR Newswire)
19.09.23	ROSEN, NATIONAL TRIAL LAWYERS, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INFI (PR Newswire)
12.09.23	ROSEN, A LEADING LAW FIRM, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INFI (PR Newswire)
27.08.23	ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INFI (PR Newswire)
20.08.23	ROSEN, A LEADING LAW FIRM, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INFI (PR Newswire)
27.04.23	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TCFC, INDT, PTRS, INFI (PR Newswire)
17.04.23	SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates INFI, ANGN, NUVA, SUMO (PR Newswire)
12.04.23	SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates TRTN, TESS, SHBI, INFI (PR Newswire)
30.03.23	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GMED, PRVB, INFI (PR Newswire)
14.03.23	SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates TA, INDT, INFI, BRMK (PR Newswire)
28.02.23	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PTRS, JNCE, INFI, HRZN (PR Newswire)
23.02.23	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INFI, HRZN, VBLT (PR Newswire)
14.11.22	Infinity Updates On Study Of Eganelisib Combination In Metastatic Triple Negative Breast Cancer (RTTNews)
04.05.22	ATRC Sees 16-20% Revenue Growth, RIGL On Watch, LUNG Breathes Easy, BPMC Braces For Busy Year (RTTNews)
30.03.22	IMAB On Watch, GTH Expects 2022 Revenue To Grow 10-20%, PHVS To Report HAE Trial Data In Q4 (RTTNews)
10.12.21	Why Infinity Pharmaceuticals Is Rising In Pre-market? (RTTNews)
07.09.21	Infinity Pharma Names Robert Ilaria As CMO And Brian Schwartz To Board - Quick Facts (RTTNews)
12.02.21	ACIU & Alzheimer's Vaccine, GNMK Rallies, ESSA's Prostate Cancer Drug On Track, MNPR On Watch (RTTNews)
20.11.20	AZN's Covid Jab & Immunosenescence, PFE/BNTX To Seek Emergency Nod For Vaccine, QURE Aces HOPE-B (RTTNews)
09.07.20	Pre-market Movers In Healthcare Sector: INFI, BNGO, ACER, UMRX… (RTTNews)
13.11.18	INFI Hits All-time Low, MESO Gets Blasted Over MPC-150-IM Data, EYEN On Watch (RTTNews)
04.06.18	Infinity Reports IPI-549 Clinical and Translational Data from Ongoing Phase 1/1b Study at American Society of Clinical Oncology Annual Meeting (PR Newswire)
08.05.18	Infinity Announces Presentations On IPI-549 At Upcoming American Society of Clinical Oncology Annual Meeting (PR Newswire)
08.05.18	Infinity Pharmaceuticals Provides Company Update and First Quarter 2018 Financial Results (PR Newswire)
01.05.18	Infinity Announces The Date Of Its First Quarter 2018 Financial Results Conference Call And Webcast (PR Newswire)
26.03.18	Infinity to Present at Two Upcoming Conferences (PR Newswire)
21.03.18	Infinity To Present At BioCentury's 25th Annual Future Leaders In The Biotech Industry Conference (PR Newswire)
15.03.18	Infinity Pharmaceuticals Provides Company Update and Reports Fourth Quarter and Full Year 2017 Financial Results (PR Newswire)
08.03.18	Infinity Announces the Date of Its Fourth Quarter and Full Year 2017 Financial Results Conference Call and Webcast (PR Newswire)
08.03.18	Infinity Pharmaceuticals Announces Additions to Board of Directors and Clinical Leadership Team and Establishes Scientific Advisory Board (PR Newswire)
06.03.18	VCEL Shines On Q4 Results, CLSD's PEACHTREE Blooms, SBPH Waiting To ACHIEVE (RTTNews)
22.02.18	Community Informational Meeting on Opioid Risks, Treatment, and Recovery at AdCare Rhode Island (PR Newswire)
05.02.18	Infinity To Present At BIO CEO & Investor Conference (PR Newswire)
09.01.18	Parkinson's Drug Hits Shelves, Major Event Awaits ABIO In Mar, FDA Nod For NVRO (RTTNews)
08.01.18	Infinity Provides Update on IPI-549 Phase 1/1b Study, 2018 Goals and Financial Guidance (PR Newswire)
28.12.17	INFI Picks Up Steam, HAIR Grows, MRSN Awaits Safety Data, SPPI Advances (RTTNews)
10.11.17	Do You Have INFI And These 6 Other Pharma Stocks In Your Portfolio? (RTTNews)
10.11.17	Infinity Pharmaceuticals Reports IPI-549 Clinical and Translational Data from Completed Monotherapy Dose-Escalation Component of Phase 1/1b Clinical Study in Patients with Advanced Solid Tumors at... (PR Newswire)
10.11.17	SAGE Goes Out On A High Note, MRNS Spirited, STAAR Shines, OPK Slumps (RTTNews)
07.11.17	Infinity Provides Company Update and Reports Third Quarter 2017 Financial Results (PR Newswire)
06.11.17	Infinity to Host Investor Reception and Webcast at SITC (PR Newswire)
30.10.17	Infinity Announces the Date of Its Third Quarter 2017 Financial Results Conference Call and Webcast (PR Newswire)
20.10.17	QURE On Fast Track, Music To CNCE's Ears, CRBP Gets A Facelift, OBLN Deflated (RTTNews)
19.10.17	SPPI Breathes Easy On Trial Results, PTI Awaits Data In Q4, HAIR Keeps Receding (RTTNews)
13.10.17	INFI Turns Heads, ARDX Marches On, VYGR Cruises Ahead, ACRX Disappoints (RTTNews)
12.10.17	Infinity Announces IPI-549 Late-Breaking Presentation at SITC Annual Meeting (PR Newswire)
10.10.17	Infinity To Present At The 2017 BIO Investor Forum (PR Newswire)
26.09.17	FDA Rejects IPCI's Painkiller, GNCA Bleeds On Herpes Vaccine News, PRQR Abuzz (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Infinity Pharmaceuticals IncShs

Aktien Top/Flop

Meistgelesene Nachrichten